Cryo-Cell International, Inc.
CCEL
$7.17
$0.14262.03%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 104.22% | -456.17% | -505.57% | -459.64% | -443.58% |
| Total Depreciation and Amortization | -40.27% | -37.53% | -33.55% | -20.36% | -5.47% |
| Total Amortization of Deferred Charges | -1.85% | -1.84% | 26.63% | 44.30% | 35.85% |
| Total Other Non-Cash Items | -91.91% | 3,317.39% | 5,057.96% | 45,252.52% | 4,008.20% |
| Change in Net Operating Assets | -38.21% | 16.63% | -4.27% | 5.55% | 40.82% |
| Cash from Operations | -32.61% | -10.08% | -23.40% | -20.56% | 4.05% |
| Capital Expenditure | 64.85% | 19.39% | 44.70% | 41.82% | 43.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.40% | -60.29% | -37.08% | 9.71% | 73.78% |
| Cash from Investing | 40.12% | -35.20% | 29.98% | 30.15% | 46.69% |
| Total Debt Issued | 449.47% | -62.89% | -75.05% | -88.58% | -94.29% |
| Total Debt Repaid | -41.87% | 36.46% | 70.86% | 73.70% | 70.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -78.19% | -53.67% | -19.32% | 41.15% | 56.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 437.78% | 102.95% | 102.87% | 99.14% | 99.14% |
| Cash from Financing | 52.76% | 69.79% | -33.22% | -180.35% | -1,501.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.93% | 83.48% | 61.04% | -45.93% | 80.21% |
